News for NOXXON Pharma N.V. (ALNOX.PA)

Experienced Healthcare Executive to Lead Finance Organization Experienced Healthcare Executive to Lead Finance Organization SEATTLE & CAMBRIDGE, Mass. & TOKYO —…

NOXXON SECURES €17 MILLION EXPANSION OF EQUITY-LINKED FACILITY WITH ATLAS TO ADVANCE NOX-A12 IN GLIOBLASTOMA AND PANCREATIC CANCER PROGRAMS ... | December 29, 2021

NOXXON ANNOUNCES CONVOCATION OF AN EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS Appointment of Bryan Jennings to the Board of Directors... | November 15, 2021

NOXXON TO PRESENT AT THE THIRD EDITION OF INVESTIR DAY ON NOVEMBER 23 IN PARIS, FRANCE Berlin, Germany, November 9, 2021, 08:00 a.m. CET -... | November 9, 2021

NOXXON Pharma N.V. Amsterdam, The Netherlands Half-Year Financial Report 2021 30 June 2021 NOXXON Pharma... | October 22, 2021

NOXXON ANNOUNCES PLANNED EXPANSION OF PHASE 1/2 NOX-A12 BRAIN CANCER TRIAL Berlin, Germany, October 19, 2021, 08:00 a.m. CEST - NOXXON... | October 19, 2021

NOXXON ENROLLS LAST BRAIN CANCER PATIENT IN DOSE ESCALATION PORTION OF GLORIA STUDY AND CONFIRMS PHASE 1/2 READ-OUT IN Q1 2022 ... | September 22, 2021

NOXXON TO ATTEND THE GERMAN FALL CONFERENCE ON SEPTEMBER 6 & 7, 2021 Berlin, Germany, August 25, 2021, 08:00 a.m. CEST - NOXXON Pharma... | August 25, 2021

Regulatory News: NOXXON Pharma N.V. , a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment , announced today the results of its 2021 annual general...